BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 28, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the company has successfully demonstrated sequencing on integrated Proteus™ instruments. This milestone was achieved using a developmental sequencing kit, the KinetIQ™ Array, and fully integrated Proteus instruments. The […]

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 16, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the first quarter 2026 on Thursday, May 7, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, […]

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 15, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that there will be two customer posters presented at the American Association of Cancer Research (AACR) annual meeting on April 17-22, 2026 in San Diego, California. Poster 2421; April […]

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 14, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a new manuscript available via pre-print on bioRxiv from researchers out of the University of British Columbia and the B.C. Cancer Research Institute. In the pre-print titled “Heterologous expression […]

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 10, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 61,439 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

Sequencing Results Utilizing a Proteus Prototype System Exceeds Platinum® Pro BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 8, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced that the Company has completed the sequencing of multiple samples provided by an existing Platinum Pro customer on […]

Multi-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 6, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the start of a roadshow designed to accelerate the education of the market on its […]

BRANFORD, Conn.–(BUSINESS WIRE)–Mar. 13, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 88,781 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 13, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 52,296 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 10, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, […]